Slate Path Capital logo

Slate Path Capital

Crunchbase
Crunchbase

Deals on record

1

Common Fundraising Type

Series A

City Therapeutics logo
City Therapeutics

Biopharmaceutical

ARCH Venture Partners logo
Regeneron Ventures logo
Rock Springs Capital logo
Slate Path Capital logo
Invus logo
Fidelity Management & Research Company logo
AN Ventures logo

City Therapeutics is a biopharmaceutical company focused on developing RNA interference-based medicines using engineered small interfering RNAs to target a broad range of diseases.

Series A
$135M
10/08/2024
Article